Opexa Pharmaceuticals
Records under this name other than patents Opexa Pharmaceuticals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Opexa Pharmaceuticals
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,744,893 | T cell receptor CDR3 sequences associated with multiple sclerosis and compositions comprising same Lapsed on the fee record Ended Jun 29, 2018 · High confidence | Lapsed on the fee record | Ended Jun 29, 2018 | High confidence |
| US 7,695,713 | Isolation and Identification of T Cells Lapsed on the fee record Ended Apr 13, 2018 · High confidence | Lapsed on the fee record | Ended Apr 13, 2018 | High confidence |
| US 7,658,926 | Autologous T-Cell Vaccines Materials and Methods Formerly held Lapsed on the fee record Ended Feb 9, 2018 · High confidence | Lapsed on the fee record | Ended Feb 9, 2018 | High confidence |